The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of IBI110 (anti-LAG-3 mAb) in combination with sintilimab (anti-PD-1 mAb) in first-line advanced squamous non-small cell lung cancer (sqNSCLC): Initial results from a phase Ib study.
 
Caicun Zhou
No Relationships to Disclose
 
Anwen Xiong
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Lei Wang
No Relationships to Disclose
 
Fengying Wu
No Relationships to Disclose
 
Jia Yu
No Relationships to Disclose
 
Chenyu Mao
No Relationships to Disclose
 
Jiong Qian
No Relationships to Disclose
 
Yulong Zheng
No Relationships to Disclose
 
Haiping Jiang
No Relationships to Disclose
 
Yuan Gao
No Relationships to Disclose
 
Cheng Xiao
No Relationships to Disclose
 
Wenxiang Wang
No Relationships to Disclose
 
Wu Zhuang
No Relationships to Disclose
 
Jun Yang
No Relationships to Disclose
 
Jiya Sun
Employment - Innovent Biologics
 
Hongli Wang
Employment - Innovent Biologics
 
Ying Liu
Employment - Innovent Biologics
 
Nong Xu
No Relationships to Disclose